Health · 30 May 2026

NHS cancer blood test trial misses main goal

A big NHS trial of a new blood test for over 50 types of cancer didn't meet its main aim to find late-stage cases earlier. The Galleri test, designed by GRAIL, was given to 142,942 patients over three years, with results shared in Chicago. It aimed to reduce diagnoses at stages three and four, but didn't statistically achieve this.

By BriefTea Editorial · 30 May 2026 at 16:06

Reported by Guardian · How we write briefs

Get the app

More briefs

HealthCorrecting hearing loss can cut dementia risk by almost half HealthMan changes life after doctor warns liver disease could kill him HealthSweetener used in chewing gum and jam linked to strokes and heart attacks HealthMouth cancer rates up a third in UK, often with no obvious cause HealthBox breathing helps calm stress and reduce anxiety, say experts HealthNHS managers warn spiralling costs could disrupt ADHD and autism care More health stories → Browse all stories →